Oncology

Colorectal cancer
#Colorectal cancer #Oncology #Phase I trial #The Institute of Cancer Research

Targeted therapy shows promise in advanced colorectal cancer

A targeted antibody therapy combined with standard chemotherapy has shown early signs of tumour shrinkage and disease control in patients with advanced bowel cancer.  This is according to new Phase I clinical trial results from The Institute of Cancer Research, London and The Royal Marsden NHS Foundation… Read More

#Cancer Research #Editor's Choice #News

Pancreatic cells
#Funding #Oncology #Pancreatic cancer

$6.7m awarded to pancreatic cancer research projects

The Stephenson Global Pancreatic Cancer Research Institute (SGPCRI) is awarding $6.7 million to eight projects in 2026.  The funded projects span the full continuum of pancreatic cancer research, from prevention and early detection to next-generation therapies.   “Every investment we make is driven by one goal:… Read More

#Cancer Research #News

Radiopharmaceutical drug
#European Medicines Agency #Oncology #Orphan drugs #Perspective Therapeutics #Radiopharmaceuticals

Perspective receives European orphan medicinal product designation

Radiopharmaceuticals company Perspective Therapeutics has received orphan medicinal product designation from the European Commission (EC) for [²¹²Pb]VMT-α-NET for the treatment of gastroenteropancreatic neuroendocrine tumours (GEP-NETs).  The designation follows a positive opinion from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA).  “Patients with unresectable or metastatic… Read More

#Cancer Research #News #Regulatory

Antibodies attack Covid-19
#Covid-19 #Dendritic cells #Immunity #Oncology

Scientists redirect Covid-19 immune memory to fight cancer

Scientists have developed a novel cancer vaccine platform that transforms the synchronised mass immune memory generated through SARS-CoV-2 infection and vaccination into a powerful ally against cancer.  The study by scientists from Celloram, University Hospitals, and Case Western Reserve University was published in Nature Communications. Read More

#Cancer Research #Editor's Choice #News

AI and robotics
#Artificial intelligence (AI) #Computational chemistry #Deep Origin #Lymphoma #Oncology

AI validates molecular glue compound that kills lymphoma cells

Deep Origin’s docking and molecular dynamics (MD) simulations have successfully rationalised researchers’ work identifying a potent compound to switch on cell-death programmes in diffuse large B cell lymphoma (DLBCL).  The study was led by researchers at Stanford University and the University of Texas MD Anderson Cancer Center. … Read More

#Cancer Research #News

Lung cancer
#Kairos Pharma #Lung cancer #Monoclonal antibodies #Oncology

New drug could change post-progression treatment of EGFR-NSCLC

Kairos Pharma has shared interim safety data from its ongoing Phase I clinical trial evaluating ENV-105 (carotuximab) in combination with osimertinib (AstraZeneca’s Tagrisso) in patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC). The company says the data represent a pivotal milestone in its lead programme: resensitising patients… Read More

#Cancer Research #News

Cancer cells
#Cancer Research UK #Clinical trials #Oncology #Peptides

Cancer Research UK leads global trial of rare cancer therapy 

Cancer Research UK is leading a group of partners launching a global Phase II trial into rare adrenal gland cancer.  Biotechnology company Cytovation and the Norwegian Cancer Society (NCS) have joined forces with Cancer Research UK for the trial of people with advanced adrenocortical carcinoma (ACC), a rare and… Read More

#News #Trending News

Organoid
#3D cell culture #Drug discovery #New approach methodologies (NAMs) #Oncology #Organoids

Why traceability will make or break the organoid revolution 

By Carolina Lucchesi, Principal Scientist and Head of Microphysiological Systems, ATCC.  Across the world, regulators are sending a consistent signal: the era of animal-only preclinical testing is drawing to a close. In the United States, the Food and Drug Administration (FDA) has committed to phasing out animal testing requirements1. The European Union and United Kingdom are moving in the same direction, with regulatory bodies… Read More

#Exclusive Content

#Haematology #Ipsen #Mergers and acquisitions #Oncology

Ipsen acquires Kartos Therapeutics in $450m deal 

Biopharmaceutical company Ipsen has agreed a deal to acquire Kartos Therapeutics, expanding its haemato-oncology late-stage pipeline.  Ipsen will pay $450 million upfront as per the terms of the agreement, with Kartos Therapeutics shareholders eligible to receive payments of up to $1.3 million subject to regulatory approval milestones and sales-based milestones.  The merger allows Ipsen to… Read More

#Business & Investment #News

#AI #ASCO #Cancer research #Clinical trial #Combination therapy #Data science #GLP-1 #Incyte #MHRA #Myeloma #Obesity #Oncology #UK #Ulcerative colitis (UC) #Weight loss

DDW Highlights: 30 June 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, researchers uncovered clues explaining risks of heart disease, lung disease, Covid-19 and… Read More

#Podcasts

KRAS
#Champions Oncology #Drug discovery #KRAS #Oncology #Patient-derived tumour models #Tumour models #Webinar

Webinar explores resistance to Pan-RAS(ON) inhibition

KRAS mutations are among the most prevalent oncogenic drivers in solid tumours, yet predicting which patients will respond to targeted therapy — and understanding why resistance inevitably emerges — remains one of the central challenges in oncology drug development. ‘Cracking KRAS: Decoding Sensitivity and Resistance to Pan-RAS(ON) Inhibition Across Patient-Derived… Read More

#News

#Bladder cancer #Covid-19 #Drug discovery #Heart disease #Lung disease #Oncology

This week in Drug Discovery (22-26 June) 

News round-up for 22–26 June by Bruno Quinney, Content Team at DDW.  This week, the Summer issue of DDW is now available to read. Elsewhere, researchers have uncovered clues explaining risks of heart disease, lung disease, Covid-19 and cancer.    The top stories: … Read More

#News

#AI #ASCO #Cancer research #Clinical trial #Combination therapy #Data science #GLP-1 #Incyte #MHRA #Myeloma #Obesity #Oncology #UK #Ulcerative colitis (UC) #Weight loss

DDW Highlights: 23 June 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, results showed the new Wegovy pill could help patients lose 17% of… Read More

#Podcasts

Bladder cancer
#Bladder cancer #Oncology #University of Edinburgh #Xiamen University

Algae microbots increase drug penetration 10x in bladder cancer

Tiny algae-based robots guided by magnets could improve bladder cancer treatment by boosting delivery of chemotherapy drugs into tumours, researchers say.   Tracked using real-time imaging, the miniature robots help drugs penetrate deep into tumour tissue while limiting damage to healthy cells.   In lab tests with… Read More

#Cancer Research #Editor's Choice #News